Mark J. Taisey

General Counsel presso AMGEN INC.

Health Technology

Consumer Services

Profilo

Mark J.
Taisey is currently the Senior VP-Global Regulatory Affairs & Strategy at Amgen, Inc. He previously worked as the Chairman-Regulatory Steering Group at Pharmaceutical Research & Manufacturers of America from 2019 to 2020, and as an Executive Director at Pfizer Inc. from 2002 to 2007.
Mr. Taisey completed his undergraduate degree at Rochester Christian University.

Posizioni attive di Mark J. Taisey

Società	Posizione	Inizio
AMGEN INC.	General Counsel	01/01/2014

Tutte le posizioni attive di Mark J. Taisey

Precedenti posizioni note di Mark J. Taisey

Società	Posizione	Fine
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Corporate Officer/Principal	01/01/2020
PFIZER, INC.	Director/Board Member	01/01/2007

Vedi nel dettaglio l'esperienza di Mark J. Taisey

Formazione di Mark J. Taisey

Rochester Christian University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark J. Taisey

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
AMGEN INC.	Health Technology
PFIZER, INC.	Health Technology

Aziende private	1
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Health Technology